Ascentage Pharma Group International (HKG:6855)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
34.00
-1.62 (-4.55%)
Jul 30, 2026, 1:00 PM HKT

HKG:6855 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
13,10219,23014,0717,7726,6367,264
Market Cap Growth
-53.91%36.66%81.06%17.11%-8.65%-14.53%
Enterprise Value
12,56519,30114,7277,8856,4756,225
Last Close Price
35.6252.2545.4527.3025.7028.20

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-154.05----
PS Ratio
20.5130.1013.4831.7827.99212.05
PB Ratio
8.8212.9548.2399.8714.364.79
P/TBV Ratio
9.5414.0180.87-19.595.15

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
19.6730.2114.1132.2427.31181.70

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.481.486.0925.424.390.88
Net Debt / Equity Ratio
-0.37-0.371.479.840.71-0.54
Net Debt / EBITDA Ratio
0.430.43-1.34-0.85-0.340.73
Net Debt / FCF Ratio
0.410.41-2.96-0.90-0.340.64
Asset Turnover
0.170.170.380.080.070.01
Inventory Turnover
2.782.782.562.383.29-
Quick Ratio
1.691.691.171.351.785.05
Current Ratio
1.791.791.261.441.865.22
Return on Equity (ROE)
-154.56%-154.56%-235.32%-386.28%-107.45%-75.18%
Return on Assets (ROA)
-23.02%-23.02%-9.25%-20.92%-19.14%-24.97%
Return on Capital Employed (ROCE)
-52.20%-52.20%-26.10%-57.00%-45.30%-36.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-10.56%-7.19%-3.07%-13.12%-15.04%-13.22%
FCF Yield
-10.21%-6.95%-1.03%-10.95%-14.60%-17.57%
Buyback Yield / Dilution
-17.90%-17.90%-7.00%-7.07%-3.56%-17.93%